HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nalmefene reverses carfentanil-induced loss of righting reflex and respiratory depression in rats.

Abstract
Reversing the respiratory depression induced by carfentanil involves intravenous administration of naloxone or naltrexone, but this treatment has disadvantages. Hence, finding a more appropriate treatment to counter the depressive actions of carfentanil is needed. In the present study, with the naloxone as a control, we investigated the efficacy of nalmefene for countering the depressive actions of carfentanil. Rats were treated successively with carfentanil (10 μg/kg, i.v.) and nalmefene (9.4-150.0 μg/kg, i.m.), and the duration of loss of righting reflex (LORR) recorded. Respiratory parameters were measured in free-moving rats using a whole-body plethysmograph after rats were administered carfentanil (20 μg/kg, i.v.) and nalmefene (9.4-150.0 μg/kg, i.m.) sequentially. The parameters of arterial blood gases were also examined. Nalmefene (9.4-150.0 μg/kg, i.m.) treatment dose-dependently decreased the duration of carfentanil-induced LORR. The respiratory rate after 60 min of nalmefene (150.0 μg/kg, i.m.) treatment increased from 34.3 ± 5.3 bursts/min to 117.8 ± 18.9 bursts/min, and enhanced pause decreased from 1.1 ± 0.1 to 0.4 ± 0.1, and was close to those of normal rats. Furthermore, nalmefene (37.5-150.0 μg/kg) treatment could enable the PaO2, SaO2 and PaCO2 to approach normal levels 10 min (15 min after carfentanil injection) or 30 min (25 min after carfentanil injection) after injection. While, a single injection of naloxone (150.0 μg/kg, i.m.) only achieved partial remission of respiratory depression. These data suggest that nalmefene more effectively counters the depressive actions induced by carfentanil and is a more appropriate treatment to antagonize carfentanil toxicity compared with naloxone.
AuthorsZheng Yong, Xiang Gao, Wentao Ma, Huajing Dong, Zehui Gong, Ruibin Su
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 738 Pg. 153-7 (Sep 05 2014) ISSN: 1879-0712 [Electronic] Netherlands
PMID24886878 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Analgesics, Opioid
  • Naltrexone
  • carfentanil
  • nalmefene
  • Fentanyl
Topics
  • Analgesics, Opioid (adverse effects, antagonists & inhibitors)
  • Animals
  • Blood Gas Analysis
  • Dose-Response Relationship, Drug
  • Fentanyl (adverse effects, analogs & derivatives, antagonists & inhibitors)
  • Male
  • Naltrexone (analogs & derivatives, pharmacology, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Reflex, Righting (drug effects)
  • Respiratory Insufficiency (chemically induced, drug therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: